Market Movers (8-K)
See all →NYSE
JPMorgan Chase & Co. announced robust third-quarter 2026 financial results, showcasing significant year-over-year growth in net income and revenue, alongside solid capital and liquidity positions.
NYSE
JPMorgan Chase & Co. announced a significant increase in third-quarter net income, driven by broad-based strength across its banking and investment divisions.
NYSE
JPMorgan Chase & Co. announced the successful closing of multiple public debt offerings, raising a total of $11 billion across senior and subordinated notes.
Capital raise
NYSE
JPMorgan Chase & Co. announced an amendment to its bylaws, effective July 21, 2026, clarifying the appointment process for its Lead Independent Director.
NYSE
JPMorgan Chase & Co. announced robust second-quarter 2026 financial results, driven by strong revenue growth across its business segments and effective expense management.
Better than expected
NYSE
JPMorgan Chase & Co. announced a significant increase in second-quarter 2026 net income, driven by strong performance across all business segments and substantial gains from investments.
Better than expected
Quarterly Earnings (10-Q)
See all →NYSE
JPMorgan Chase posted 12% higher Q3 net income on strong Markets and investment banking, boosted buybacks and raised its dividend amid robust capital and liquidity.
Better than expected
Capital raise
NYSE
JPMorgan Chase & Co. reported a 17% decline in second-quarter net income to $15.0 billion, primarily due to the absence of a significant one-time gain from Visa shares in the prior year.
Worse than expected
NYSE
JPMorgan Chase's Q1 2025 net income increased by 9% to $14.6 billion, driven by growth in noninterest revenue and effective cost management, despite challenges in net interest income.
NYSE
JPMorgan Chase's Q3 2024 results show a slight decrease in net income despite a revenue increase, influenced by credit normalization and strategic balance sheet adjustments.
Worse than expected
NYSE
JPMorgan Chase's second quarter results were boosted by a significant gain from Visa shares, leading to a 25% increase in net income.
Better than expected
NYSE
JPMorgan Chase's first quarter results show a 6% increase in net income to $13.4 billion, driven by strong net interest income and the impact of the First Republic acquisition.
Better than expected
Annual Reports (10-K)
NYSE
JPMorgan Chase's 2024 10-K filing reveals a year of strong financial performance amidst regulatory scrutiny and strategic business reorganizations.
Delay expected
NYSE
JPMorgan Chase's 10-K filing details the various securities issued and guaranteed by the company, including common and preferred stock, ETNs, and notes.
Insider Trading (Form 4)
See all →NYSE
Stephen B Burke, a Director of Jpmorgan Chase & Co, reported a transaction in 30,000 shares of common stock on October 14, 2026.
NYSE
Virginia M Rometty, a Director of Jpmorgan Chase & Co, received 121 shares of common stock on September 30, 2026.
NYSE
Phebe N Novakovic, a Director of Jpmorgan Chase & Co, received 121 shares of common stock on September 30, 2026.
NYSE
Mellody L Hobson, a Director of Jpmorgan Chase & Co, received 136 shares of common stock on September 30, 2026.
NYSE
Stephen B Burke, a Director of Jpmorgan Chase & Co, received 170 shares of common stock on September 30, 2026.
NYSE
Robin Leopold, Head of Human Resources of Jpmorgan Chase & Co, sold 2,500 shares of common stock on September 10, 2026 for $352.81 per share.
Proxy Statements (Def-14A)
See all →NYSE
JPMorgan Chase & Co. has released its 2026 proxy statement, highlighting record 2025 financial performance and outlining proposals for the upcoming annual meeting.
NYSE
DEFA14A: JPMorgan Chase Defends Leadership Structure Against ISS Recommendation for Independent Chair
JPMorgan Chase is publicly disputing Institutional Shareholder Services' (ISS) recommendation for an independent board chair, arguing its current leadership structure has delivered superior performance and shareholder returns.
Worse than expected
NYSE
JPMorgan Chase is urging shareholders to reject a proposal for an independent board chairman, citing strong financial performance under the current combined CEO/Chair role and the board's commitment to a future separation upon CEO transition.
NYSE
JPMorgan Chase & Co. has filed a definitive proxy statement with the SEC.
NYSE
JPMorgan Chase & Co. has filed a definitive proxy statement with the SEC.
NYSE
JPMorgan Chase & Co. releases its proxy statement, outlining key proposals for the 2025 annual meeting, including director elections and executive compensation.
Institutional Holdings (13F)
See all →NYSE
Jpmorgan Chase & Co reported 34,064 holdings worth $1,807.0B for the period ended June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed an amended Form 13F, reporting a total of 33,063 holdings with a total value of over $1.55 trillion as of March 31, 2026.
NYSE
JPMorgan Chase & Co. filed its Q1 2026 13F holdings report, detailing a vast portfolio of over 33,000 securities valued at over $1.5 trillion.
NYSE
JPMorgan Chase & Co. filed its Q4 2025 13F-HR report, revealing over $1.59 trillion in managed assets across 31,795 positions.
NYSE
JPMorgan Chase & Co. filed an amendment to its Q3 2025 13F report, adding new holdings entries and detailing over $1.6 trillion in managed assets.
NYSE
JPMorgan Chase & Co. has filed its Q3 2025 13F-HR report, revealing a vast portfolio of $1.67 trillion across 32,847 securities.
Schedule 13D - Activist Investments
See all →NYSE
JPMorgan Chase & Co. and DNT Asset Trust file an amendment to their Schedule 13D regarding Blackrock MuniHoldings Fund, Inc. Preferred Shares, updating purchase and registration rights agreements.
NYSE
JPMorgan Chase & Co. and DNT Asset Trust filed an amendment to their Schedule 13D regarding the deposit of 7,178 preferred shares into a tender option bond trust.
NYSE
JPMorgan Chase & Co. and DNT Asset Trust have sold all their Variable Rate Demand Preferred Shares in BlackRock MuniYield Quality Fund, Inc. for $100,000 per share.
NYSE
JPMorgan Chase & Co. and DNT Asset Trust increased their beneficial ownership in BlackRock MuniYield Quality Fund, Inc. to 17.26% following a fund reorganization.
NYSE
JPMorgan Chase & Co. and DNT Asset Trust have ceased beneficial ownership in BlackRock Investment Quality Municipal Trust, Inc. following a reorganization.
NYSE
JPMorgan Chase & Co. and DNT Asset Trust have ceased beneficial ownership of BlackRock MuniYield Quality Fund II, Inc. preferred shares following a reorganization into BlackRock MuniYield Quality Fund, Inc.
Schedule 13G - Passive Investments
See all →NYSE
JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Ciena Corporation common stock.
NYSE
JPMorgan Chase & Co. has disclosed beneficial ownership of 4.0% of Vicor Corporation's common stock, totaling 1,394,339 shares, as of August 31, 2026.
NYSE
SCHEDULE: JPMorgan Chase Reports Stake in MKS Inc.
JPMorgan Chase & Co. has filed a Schedule 13G, indicating a beneficial ownership stake of 2.9% in MKS Inc.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, disclosing beneficial ownership of 4.9% of Lamb Weston Holdings, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 38,598,106 shares, representing 7.4% of 3M Company's common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 7.6% of Warner Music Group Corp.'s Class A Common Stock as of June 30, 2026.